![](/img/cover-not-exists.png)
193P A phase 1 study evaluating the pharmacokinetics (PK), safety, and efficacy of regorafenib (REG) in Chinese patients with advanced, refractory solid tumors
Cao, J., Ji, D., Shen, W., Wang, Q., Liu, Y., Lu, D., Sturm, I., Huang, F., Cleton, A.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw581.026
Date:
December, 2016
File:
PDF, 70 KB
english, 2016